BioPharma Today

Shionogi Spurns Europe, Places Bets On Asia For Global Expansion - Bio Expo Japan

TOKYO - Shionogi, set on global expansion, has rejected initial plans to expand into Europe, instead turning to emerging markets in Asia

Indian Companies Are Becoming More Creative, Says Astellas India Managing Director Teruo Yasufuku: An Interview With PharmAsia News

Teruo Yasufuku, managing director for Astellas Pharma India, is soft-spoken and carefully measures every answer that he shares with the media. But the law graduate who started his career as a medical representative with Fujisawa in 1983 has been recognized for his leadership skills and the enthusiasm to be the best in the business.

Latest News from "The Pink Sheet" DAILY - Endo Explains HealthTronics Acquisition to Wall Street

Endo Explains HealthTronics Acquisition to Wall Street: Relationships With Urologists Are Key

Endo's pending acquisition of HealthTronics and its settlement with Impax and Sandoz over generic Opana ER removes some near-term pressure on its shares.   read more

Will Sanofi-Aventis Succeed In India With Its Rural Strategy?

In this complimentary report, PharmAsia News takes a closer look at R&D strategies in Asia, focusing on India, China and Korea. In India, Sanofi-Aventis's media-shy leader Shailesh Ayyangar sits down with PharmAsia News in a rare interview to discuss Sanofi's strategy in rural markets.

Big Brand Fights Come To India As Januvia, Galvus And Onglyza Vie For Market Share

MUMBAI - Marketing of patented and branded drugs is a relatively new concept in India but going by the initial strategies put into play by multinational companies - most notably for the DPP-4 inhibitors Januvia (sitagliptin), Galvus (vildagliptin) and Onglyza (saxagliptin) - it has all the ingredients of blowing up into an all out war in the race to capture the mind recall of doctors.

The Rise Of Japanese Pharma Dealmakers

Japanese pharmas are now serious contenders for partnerships outside their home country, increasing their spending on both alliances and acquisitions in recent years. The increased desire to partner with Western biotechs is good news for smaller industry players as the recent spate of mega-mergers has resulted in a smaller pool of potential acquirers for their assets.

Mylan Preps India Rollout - Latest From PharmAsia News

Massive U.S. Government Delegation Seeks Common Ground In China To Counter Threats To Peace And Health, Including Future Pandemics

05/27/10 12:44 GMT

Japanese And Chinese Regulators Step Up Communication - Latest From PharmAsia News

Japanese, Chinese Regulators Step Up Communications To Increase Effectiveness, Speed Up Approval - DIA China Conference

05/26/10 11:59 GMT

Abbott, Piramal, Dong-A, Astellas - Latest From PharmAsia News

MNCs Return To India With Big Bang; Some Call It Their Waterloo, Others Say Time To Grow Strong

05/25/10 10:11 GMT

Korean Dong-A In Talks With Warner Chilcott For Additional Indications For ED Drug Zydena

05/25/10 10:03 GMT

Astellas Looks Up In 2010; Eisai Draws Growth From Domestic And Chinese Markets: Japanese Pharma Earnings Roundup (Part 1 Of 2)

05/25/10 9:11 GMT

“PharmAsia News” Delivers highly specialized industry insight on the rapidly expanding Asian marketplace, including analysis of regulatory and commercial developments from bureaus across Asia, exclusive interviews, special guest columns, continuously updated newsfeeds and editor's picks from Asia.  Sign Up for a Free Trial Today! Click here

Latest News from "The Pink Sheet" DAILY - Genzyme, Pfizer and Abbott News

FDA's Data Falsification Proposed Rule Is Overly Strict, Sponsors Say

Agency needs to better define the evidence threshold for reporting suspected clinical trial fraud to the agency, industry commenters say.   read more